- Report
- March 2026
- 149 Pages
Global
From €2683EUR$2,999USD£2,299GBP
€3577EUR$3,999USD£3,065GBP
- Report
- April 2026
- 148 Pages
Global
From €2683EUR$2,999USD£2,299GBP
€3577EUR$3,999USD£3,065GBP
- Report
- August 2026
- 106 Pages
Global
From €4249EUR$4,750USD£3,641GBP
- Report
- July 2026
- 120 Pages
Global
From €4249EUR$4,750USD£3,641GBP
- Report
- July 2026
- 160 Pages
Global
From €4249EUR$4,750USD£3,641GBP
- Report
- July 2026
- 120 Pages
Global
From €4249EUR$4,750USD£3,641GBP
- Report
- July 2026
- 110 Pages
Global
From €4249EUR$4,750USD£3,641GBP
- Report
- July 2026
- 70 Pages
Global
From €4249EUR$4,750USD£3,641GBP
- Report
- July 2026
- 90 Pages
Global
From €4249EUR$4,750USD£3,641GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2495EUR$2,789USD£2,138GBP
- Report
- May 2026
- 400 Pages
Global
From €4427EUR$4,949USD£3,793GBP
- Report
- May 2026
- 150 Pages
Global
From €2414EUR$2,699USD£2,069GBP
- Report
- May 2026
- 400 Pages
Global
From €3461EUR$3,869USD£2,965GBP
- Report
- July 2026
- 160 Pages
Global
From €2970EUR$3,320USD£2,545GBP
€3712EUR$4,150USD£3,181GBP
- Report
- April 2026
- 160 Pages
Global
From €2970EUR$3,320USD£2,545GBP
€3712EUR$4,150USD£3,181GBP
- Report
- February 2026
- 160 Pages
Global
From €2970EUR$3,320USD£2,545GBP
€3712EUR$4,150USD£3,181GBP
- Report
- November 2025
- 145 Pages
Global
From €3534EUR$3,950USD£3,027GBP
- Report
- February 2026
- 144 Pages
Global
From €3534EUR$3,950USD£3,027GBP
- Report
- January 2026
- 128 Pages
Global
From €3534EUR$3,950USD£3,027GBP
- Report
- October 2025
- 150 Pages
Global
From €4339EUR$4,850USD£3,717GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more